Aardvark Therapeutics Expands Phase 3 HERO Trial Eligibility for ARD-101 in Prader-Willi Syndrome After FDA Protocol Alignment

Aardvark Therapeutics Inc. (NASDAQ: AARD) is one of the best young stocks with huge upside potential. On October 8, Aardvark ...
Computerworld

OpenAI: Latest news and insights

OpenAI is an artificial intelligence organization comprised of the non-profit OpenAI, Inc. and several for-profit subsidiaries. The company is perhaps best known for its ChatGPT chatbot, which ...
Frontiers

Emerging role of CAR-T cell therapy in autoimmune rheumatic diseases: mechanisms, clinical progress, and future directions

Autoimmune rheumatic diseases (ARDs), such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and systemic ...